Since CBX3 KO can render IFNγ-insensitive CRC cells becoming dramatically sensitive to IFNγ stimulation, we further investigated whether this restored sensitivity to IFNγ could make CBX3 KO CRC cells more sensitive to chemotherapy. Here, IFNG is linked to colorectal carcinoma.